ArticleRegenerative therapy2026
Long-term expandable auricular chondrocytes reveal a conserved nine-gene decline module underlying senescence-independent dedifferentiation.
Article in Regenerative therapy, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Primary chondrocytes often lose matrix-forming capacity during in vitro expansion, limiting scalable cartilage engineering. Here, we examined aging-independent regulation of chondrogenic function during long-term expansion of primary auricular chondrocytes and sought molecular features associated with late-passage functional decline. Methods: Mouse auricular chondrocytes (mACs) were serially expanded in 2D culture up to passage 40 or 50 (P50) under high- or low-seeding conditions. Proliferation, morphology, and senescence status were assessed by growth curves, phase-contrast imaging, and SA-β-gal staining. Chondrogenic capacity was evaluated using 3D pellet culture and toluidine blue staining. Bulk RNA sequencing of matched 2D and 3D samples was followed by PCA, differential expression, and pathway enrichment analyses. Key transcriptional signatures were validated by RT-qPCR in mouse auricular chondrocytes. Results: Both seeding conditions supported sustained proliferation across extended passaging. Although not immortalized, mACs maintained stable proliferation for more than P 50 with minimal senescence-associated features, exhibiting cell line-like proliferative behavior. Despite preserved growth, proteoglycan-rich matrix production declined at P50. Transcriptomic analyses identified culture dimensionality as the dominant source of variance, with 2D cultures showing passage-dependent drift and 3D pellets retaining a more stable chondrogenic profile. Cross-comparisons identified a conserved nine-gene decline module ( Conclusion: Auricular chondrocytes exhibit cell line-like proliferative capacity with limited senescence activation while progressively losing matrix-forming competence at ultra-late passages. A conserved nine-gene decline module provides molecular benchmarks for passage-resolved assessment and may inform optimization of scalable auricular cartilage manufacturing.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.